Výsledky vyhledávání

Dysplastic Recurrence After Successful Treatment for Early Barrett's Neoplasia

Publikováno v: van Munster, S N, Nieuwenhuis, E, Bisschops, R, Willekens, H, Weusten, B L A M, Herrero, L A, Bogte, A, Alkhalaf, A, Schenk, E B E, Schoon, E J, Curvers, W, Koch, A D, de Jonge, P J F, Tang, T J, Nagengast, W B, Westerhof, J, Houben, M H M G, Seewald, S, Eijkemans, M J C, Bergman, J J G H M & Pouw, R E 2022, ' Dysplastic Recurrence After Successful Treatment for Early Barrett's Neoplasia : Development and Validation of a Prediction Model ', Gastroenterology, vol. 163, no. 1, pp. 285-294 . https://doi.org/10.1053/j.gastro.2022.03.020
Gastroenterology, 163(1), 285-294. W.B. Saunders
Gastroenterology, 163(1), 285-294. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 163(1), 285-294. Elsevier Saunders
Gastroenterology, 163(1), 285-294. W.B. Saunders Ltd

BACKGROUND & AIMS: The combination of endoscopic resection and radiofrequency ablation is the treatment of choice for eradication of Barrett's esophagus (BE) with dysplasia and/or early cancer. Currently, there are no evidence-based recommendations o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3936ea93fa69dda237e57610847393
https://doi.org/10.1053/j.gastro.2022.03.020

Zobrazit plný text záznamu

Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasia

Publikováno v: Van Munster, S N, Frederiks, C N, Nieuwenhuis, E A, Alvarez Herrero, L, Bogte, A, Alkhalaf, A, Schenk, B E, Schoon, E J, Curvers, W L, Koch, A D, Van De Ven, S E M, De Jonge, P J F, Tang, T J, Nagengast, W B, Peters, F T M, Westerhof, J, Houben, M H M G, Bergman, J J G H M, Pouw, R E & Weusten, B L A M 2022, ' Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasia ', Endoscopy, vol. 54, no. 3, pp. 229-240 . https://doi.org/10.1055/a-1521-6318
Endoscopy, 54(3), 229-240. GEORG THIEME VERLAG KG
Endoscopy, 54(3), 229-240. Georg Thieme Verlag

Background Endoscopic eradication therapy with radiofrequency ablation (RFA) is effective in most patients with Barrett’s esophagus (BE). However, some patients experience poor healing and/or poor squamous regeneration. We evaluated incidence and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0bc326846e835e509c1806c56d4479
https://doi.org/10.1055/a-1521-6318

Zobrazit plný text záznamu

Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early Neoplasia

Autor: Sanne N. van Munster, Esther Nieuwenhuis, Raf Bisschops, Hilde Willekens, Bas L.A. M. Weusten, Lorenza Alvarez Herrero, Auke Bogte, Alaa Alkhalaf, Ed B.E. Schenk, Erik J. Schoon, Wouter Curvers, Arjun D. Koch, Pieter Jan F. de Jonge, Tjon J. Tang, Wouter B. Nagengast, Jessie Westerhof, Martin H.M. G. Houben, Jacques J.G. H.M. Bergman, Roos E. Pouw

Publikováno v: Clinical Gastroenterology and Hepatology, 20(11), 2495-2504.e5. W.B. Saunders
van Munster, S N, Nieuwenhuis, E, Bisschops, R, Willekens, H, Weusten, B L A M, Herrero, L A, Bogte, A, Alkhalaf, A, Schenk, E B E, Schoon, E J, Curvers, W, Koch, A D, de Jonge, P J F, Tang, T J, Nagengast, W B, Westerhof, J, Houben, M H M G, Bergman, J J G H M & Pouw, R E 2022, ' Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early Neoplasia ', Clinical Gastroenterology and Hepatology, vol. 20, no. 11, pp. 2495-2504.e5 . https://doi.org/10.1016/j.cgh.2022.02.057
Clinical Gastroenterology and Hepatology, 20(11), 2495-2504.e5. W.B. Saunders Ltd
Clinical gastroenterology and hepatology, 20(11), 2495-2504.e5. Elsevier Science
Clinical gastroenterology and hepatology, 20(11), 2495-2504.e5. W.B. Saunders Ltd

BACKGROUND & AIMS: Endoscopic eradication therapy for Barrett's esophagus (BE)-related neoplasia is safe and leads to complete eradication in the majority of patients. However, a subgroup will experience a more complex treatment course with a risk fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dc0ddf6eea1a7f8814ca0a71aa040aa
https://pure.eur.nl/en/publications/758a7da6-ccbc-4f41-ba99-da0c8cf7a07f

Zobrazit plný text záznamu

Extending treatment criteria for Barrett's neoplasia: Results of a nationwide cohort of 138 endoscopic submucosal dissection procedures

Publikováno v: Endoscopy, 54(6), 531-541. Georg Thieme Verlag
van Munster, S N, Verheij, E P D, Nieuwenhuis, E A, Offerhaus, J G J A, Meijer, S L, Brosens, L A A, Weusten, B L A M, Alkhalaf, A, Schenk, E B E, Schoon, E J, Curvers, W L, van Tilburg, L, van de Ven, S E M, Tang, T J, Nagengast, W B, Houben, M H M G, Seldenrijk, K C A, Bergman, J J G H M, Koch, A D & Pouw, R E 2022, ' Extending treatment criteria for Barrett's neoplasia : Results of a nationwide cohort of 138 endoscopic submucosal dissection procedures ', Endoscopy, vol. 54, no. 6, pp. 531-541 . https://doi.org/10.1055/a-1658-7554
Endoscopy, 54(06), 531-541. Georg Thieme Verlag

Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for treatment of neoplasia in Barrett’s esophagus (BE). We aimed to report outcomes of all ESDs for BE neoplasia performed in the Netherlands. Methods Retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5d5586eab365ec67cecfb933db7568
https://research.vumc.nl/en/publications/c7ceabf7-6e9c-4d3d-a7a0-31485ed18343

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání